ICCM News and Press, IceCure Medical Ltd. From 11/08/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock IceCure Medical (NASDAQ: ICCM ) stock is taking off on Tuesday as investors react to an update for Medicare coverage of breast cancer patients . The big news investors need to know about ...

IceCure Medical ( NASDAQ: ICCM ) stock rose ~44% on Tuesday after the company said its ProSense system for breast cancer cryoablation procedures was assigned to a Medicare payment group for hospital outpatient payment. The Centers for Medicare & Medicaid Ser...

IceCure's ProSense® Achieves Significant Milestone in Medicare Coverage of Breast Cancer Procedures PR Newswire Receives assignment to a Medicare Payment Group for hospital outpatient payment Marks CMS's first payment assignment for cryoablation of...

IceCure Launches Global #FreezeCancerNotYourLife Movement During Breast Cancer Awareness Month PR Newswire ProSense® minimally invasive breast cancer procedure destroys tumors, freezing cancer in its tracks, empowering women to walk out of the procedure and back...

The shares of Israeli medical device maker IceCure Medical Ltd ( NASDAQ: ICCM ) added ~19% pre-market Wednesday after the company announced it submitted a regulatory filing to obtain FDA clearance for ProSense System to treat breast cancer. ProSense System is designed ...

IceCure Files De Novo Classification Request with the FDA for Marketing Authorization of ProSense® with Breakthrough Indication: Early-Stage Low-Risk Breast Cancer Patients at High Risk to Surgery PR Newswire 43,000 cases estimated annually in the U.S. alone f...

IceCure Medical's ProSense® Cryoprobes and Introducers Receive Regulatory Approval in Brazil PR Newswire Regulatory filing submitted by KTRFIOS, IceCure's distributor in Brazil ProSense Cryoablation System approval in Brazil is pending ...

IceCure Submits Regulatory Filing in Vietnam for Approval of ProSense® PR Newswire Company is rapidly expanding its global regulatory and commercial reach CAESAREA, Israel , Aug. 29, 2022 /PRNewswire/ -- IceCure Medical Ltd . (NASDAQ: ICC...

IceCure Medical Ltd (ICCM) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Eyal Shamir – Chief Executive Officer Ronen Tsimerman – Chief Financial Officer Kenneth Tomkovich – Co-Primary Investigator Conf...

IceCure Medical press release ( NASDAQ: ICCM ): 1H GAAP EPS of -$0.24 (vs. -$0.16 Y/Y). Revenue of $1.5M (-28.6% Y/Y) beats by $0.75M . For further details see: IceCure Medical 1H GAAP EPS of -$0.24, revenue of $1.5M beats by $0.75M